Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCAD-ALIGN Trial
NCT07683923Phase 4Not yet recruiting
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Mar 2027
- Primary completion
- Feb 2033
- Countries
- 5
01
Overview
A Phase 4 trial of aspirin, clopidogrel in spontaneous coronary artery dissection (SCAD), acute coronary syndrome (ACS), sponsored by University Medical Center Hamburg-Eppendorf. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
spontaneous coronary artery dissection (SCAD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07683923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683923.